← FDA Drug Approvals (Drugs@FDA)

FEBUXOSTAT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2019-07-01

Drug application

FDA Application #

ANDA205385

Application type

Abbreviated New Drug Application (Generic)

Brand name

FEBUXOSTAT

Generic name

Febuxostat

Active ingredients

FEBUXOSTAT

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2019-07-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown